Synthetically Engineered SARS-CoV-2 Spike Mutant Designed for Biocompatibility and Drug Resistance

In this study, I generated a synthetic SARS-CoV-2 Spike protein based on the XBB.1.5 (XFG) lineage, introducing 19 biologically plausible mutations aimed at modeling immune escape, drug resistance, and structural fitness. These mutations were selected to preserve viral function while exploring evolutionary pathways that could impact receptor binding, antibody recognition, and vaccine efficacy. Using computational tools such as SWISS-MODEL and PyMOL, I validated the structural plausibility of the mutant and confirmed its similarity to natural variants in conformational space. Subsequently, I performed a Codon Pair Bias Index (CPBI) analysis across over 3,000 natural SARS-CoV-2 genomes and compared them with synthetic construct that I created for this study. Surprisingly, the synthetic spike showed no significant deviation from the natural population in terms of codon pair frequency or adaptation index. Its CPBI score fell within the expected distribution of natural isolates, suggesting that engineered sequences designed under natural codon constraints may not be distinguishable from evolved ones using current genomic signature-based methods . This work highlights the limitations of existing synthetic signal detection approaches , particularly when synthetic constructs are optimized for host codon compatibility and structural fidelity. Biological Plausibility Over Engineering Signatures The synthetic Spike variant was constructed using mutation strategies that: Mimic known natural variation Maintain physicochemical properties Avoid rare codons or unnatural codon pairs Preserve structural integrity and folding energy As a result, despite being computationally engineered, the mutant exhibits codon pair frequencies consistent with natural isolates , making it indistinguishable from naturally occurring strains using standard CPBI metrics. Implications for Biosecurity Detection This suggests a critical limitation in current genomic surveillance techniques : A synthetic virus designed with care to match natural codon usage can evade detection by CPBI-based algorithms. This has important implications for: Biosecurity monitoring Synthetic origin detection Future design of pathogen engineering safeguards Conclusion: Rejection of CPBI as Sole Indicator I conclude that CPBI alone cannot reliably distinguish engineered from naturally evolving sequences when synthetic designs are guided by biological constraints and codon optimization principles. While CPBI remains a powerful tool for identifying obviously engineered constructs , its utility diminishes when synthetic genes are designed to mimic natural variation . This opens new questions around: How to define "unnatural" mutation. The need for multi-layered detection frameworks As the sole author and researcher of this study and its accompanying data, I declare that I have no competing interests. This work has been designed to be fully reproducible, and the dataset and related materials are available on Zenodo. For additional files, collaboration opportunities, or to further develop this research, I can be contacted via tahirhb.com or by email at [e-mail] References:Coleman et al., 2008 Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008).Variable large-scale synthesis of genes: transgenes in plants as an example . Nucleic Acids Research , 36(2), e25.https://doi.org/10.1093/nar/gkn005 Jackson et al., 2022 Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022).Mechanisms of SARS-CoV-2 spike protein binding and entry into host cells . Annual Review of Medicine , 73, 39–54.https://doi.org/10.1146/annurev-med-041521-021418 Waterhouse et al., 2018 Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Peer, G., ... & Schwede, T. (2018).SWISS-MODEL: homology modelling of protein structures and complexes . Nucleic Acids Research , 46(W1), W399–W404.https://doi.org/10.1093/nar/gky427 Guex & Peitsch, 1997 Guex, N., & Peitsch, M. C. (1997).SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative biomolecular modeling and visualization of molecular surfaces, dynamics and mutations . Electrophoresis , 18(15), 2714–2723.https://doi.org/10.1002/elps.1150181505 Reference:Kelle et al., 2020 Kelle, A., Evans, N. G., & Altice, F. L. (2020).Dual-use risks of genome editing technologies: CRISPR and synthetic biology . Science and Public Policy , 47(5), 645–657.https://doi.org/10.1093/scipol/scz049 Gronvall et al., 2021 Gronvall, G. K., & Kahn, J. S. (2021).Synthetic virology and global health security . Nature Reviews Microbiology , 19(4), 201–202.https://doi.org/10.1038/s41579-020-00483-z DeLano, 2002 DeLano, W. L. (2002).The PyMOL Molecular Graphics System . DeLano Scientific LLC , San Carlos, CA. Hadfield et al., 2018 Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., ... & Bedford, T. (2018).Nextstrain: real-time tracking of pathogen evolution . Bioinformatics , 34(23), 4121–4123.https://doi.org/10.1093/bioinformatics/bty407 Shu & McCauley, 2017 Shu, Y., & McCauley, J. (2017).GISAID: Global initiative on sharing all influenza data – from vision to reality . Eurosurveillance , 22(13), 30494.https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494 Clark et al., 2021 Clark, K., Coombes, B., Karsch-Mizrachi, I., Ostell, J., Sayers, E. W. (2021).GenBank . Nucleic Acids Research , 49(D1), D102–D106.https://doi.org/10.1093/nar/gkaa974 Greaney et al., 2021 Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., ... & Bloom, J. D. (2021).Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies . Nature Immunology , 22(12), 1493–1501.https://doi.org/10.1038/s41590-021-01038-9 Starr et al., 2020 Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Navarro, M. J., ... & Bloom, J. D. (2020).Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding . Cell , 182(5), 1294–1310.e20.https://doi.org/10.1016/j.cell.2020.08.050 Shmakov et al., 2021 Shmakov, S. A., Yevshin, I. S., Sharipov, R. N., & Kolchanov, N. A. (2021).Designing synthetic DNA sequences with reduced bias in codon pair usage . BMC Bioinformatics , 22(1), 1–11.https://doi.org/10.1186/s12859-021-04482-9 Jumper et al., 2021 Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021).Highly accurate protein structure prediction with AlphaFold2 . Nature , 596, 583–589.https://doi.org/10.1038/s41586-021-03819-2 Cock et al., 2009 Cock, P. J., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., ... & de Hoon, M. J. (2009).Biopython: freely available Python tools for computational molecular biology and bioinformatics . Bioinformatics , 25(11), 1422–1423.https://doi.org/10.1093/bioinformatics/btp163 Fecher & Friesike, 2014 Fecher, B., & Friesike, S. (2014).Open science: one term, five schools of thought . EPJ Data Science , 3(1), 1–12.https://doi.org/10.1140/epjds/s13111-014-0006-3本研究基于XBB.1.5（XFG）谱系构建了一株人工合成的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白，引入了19个生物学合理的突变，旨在模拟免疫逃逸、耐药性及结构适配性。所选突变在保留病毒功能的同时，探索了可能影响受体结合、抗体识别及疫苗效力的进化路径。 使用SWISS-MODEL与PyMOL等计算工具，本研究验证了该突变体的结构合理性，并确认其构象空间与天然变异株高度相似。随后，针对3000余株天然SARS-CoV-2基因组开展了密码子对偏好指数（Codon Pair Bias Index, CPBI）分析，并将其与本研究构建的人工合成序列进行对比。 令人意外的是，该人工合成刺突蛋白在密码子对频率或适应指数上与天然种群无显著差异。其CPBI评分处于天然分离株的预期分布范围内，这表明在天然密码子约束下设计的工程化序列，无法通过当前基于基因组特征的方法与自然进化序列区分开来。 本研究凸显了现有合成信号检测方法的局限性，尤其是当人工构建体针对宿主密码子兼容性与结构保真度进行优化时。 ### 生物学合理性优先于工程特征 该人工合成刺突变异株的构建策略遵循以下原则： 1. 模拟已知的天然变异 2. 维持理化性质稳定 3. 规避稀有密码子或非天然密码子对 4. 保留结构完整性与折叠能量 因此，尽管该突变体为计算工程化产物，其密码子对频率与天然分离株一致，无法通过标准CPBI指标与天然流行毒株区分。 ### 生物安全检测的启示 这表明当前基因组监测技术存在关键局限： 经过精心设计以匹配天然密码子使用模式的合成病毒，可逃脱基于CPBI的算法检测。 这对以下领域具有重要意义： - 生物安全监测 - 合成起源检测 - 病原体工程防护的未来设计 ### 结论：拒绝将CPBI作为唯一判定指标 本研究得出结论：当合成序列的设计遵循生物学约束与密码子优化原则时，仅依靠CPBI无法可靠区分工程化序列与自然进化序列。 尽管CPBI仍是识别明显工程化构建体的有力工具，但当合成基因被设计为模拟天然变异时，其效用会显著下降。 这引出了一系列新的问题： - 如何定义“非天然”突变 - 构建多层级检测框架的必要性 作为本研究及配套数据的唯一作者与研究者，本人声明无任何利益冲突。本研究设计为完全可复现，数据集及相关材料已上传至Zenodo平台。如需获取附加文件、开展合作或进一步推进本研究，可通过tahirhb.com或电子邮箱[e-mail]联系本人。 #### 参考文献 1. Coleman et al., 2008 Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008). 大规模基因可变合成：以植物转基因为例. 核酸研究（Nucleic Acids Research）, 36(2), e25. https://doi.org/10.1093/nar/gkn005 2. Jackson et al., 2022 Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022). SARS-CoV-2刺突蛋白结合并进入宿主细胞的机制. 医学年度评论（Annual Review of Medicine）, 73, 39–54. https://doi.org/10.1146/annurev-med-041521-021418 3. Waterhouse et al., 2018 Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Peer, G., ... & Schwede, T. (2018). SWISS-MODEL：蛋白质结构与复合物的同源建模. 核酸研究, 46(W1), W399–W404. https://doi.org/10.1093/nar/gky427 4. Guex & Peitsch, 1997 Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL与Swiss-PdbViewer：用于比较生物分子建模及分子表面、动力学与突变可视化的环境. 电泳（Electrophoresis）, 18(15), 2714–2723. https://doi.org/10.1002/elps.1150181505 5. Kelle et al., 2020 Kelle, A., Evans, N. G., & Altice, F. L. (2020). 基因组编辑技术的两用风险：CRISPR与合成生物学. 科学与公共政策（Science and Public Policy）, 47(5), 645–657. https://doi.org/10.1093/scipol/scz049 6. Gronvall et al., 2021 Gronvall, G. K., & Kahn, J. S. (2021). 合成病毒学与全球卫生安全. 自然综述·微生物学（Nature Reviews Microbiology）, 19(4), 201–202. https://doi.org/10.1038/s41579-020-00483-z 7. DeLano, 2002 DeLano, W. L. (2002). PyMOL分子图形系统. DeLano Scientific LLC, 加利福尼亚州圣卡洛斯市. 8. Hadfield et al., 2018 Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., ... & Bedford, T. (2018). Nextstrain：病原体进化的实时追踪. 生物信息学, 34(23), 4121–4123. https://doi.org/10.1093/bioinformatics/bty407 9. Shu & McCauley, 2017 Shu, Y., & McCauley, J. (2017). GISAID：全球共享所有流感数据倡议——从愿景到现实. 欧洲监测（Eurosurveillance）, 22(13), 30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494 10. Clark et al., 2021 Clark, K., Coombes, B., Karsch-Mizrachi, I., Ostell, J., Sayers, E. W. (2021). 基因库（GenBank）. 核酸研究, 49(D1), D102–D106. https://doi.org/10.1093/nar/gkaa974 11. Greaney et al., 2021 Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., ... & Bloom, J. D. (2021). SARS-CoV-2受体结合域突变的全面图谱：影响多克隆人血浆抗体识别的突变. 自然·免疫学（Nature Immunology）, 22(12), 1493–1501. https://doi.org/10.1038/s41590-021-01038-9 12. Starr et al., 2020 Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Navarro, M. J., ... & Bloom, J. D. (2020). SARS-CoV-2受体结合域的深度突变扫描揭示折叠与ACE2结合的约束. 细胞, 182(5), 1294–1310.e20. https://doi.org/10.1016/j.cell.2020.08.050 13. Shmakov et al., 2021 Shmakov, S. A., Yevshin, I. S., Sharipov, R. N., & Kolchanov, N. A. (2021). 设计密码子对使用偏好性降低的合成DNA序列. BMC生物信息学（BMC Bioinformatics）, 22(1), 1–11. https://doi.org/10.1186/s12859-021-04482-9 14. Jumper et al., 2021 Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021). 利用AlphaFold2实现高精度蛋白质结构预测. 自然, 596, 583–589. https://doi.org/10.1038/s41586-021-03819-2 15. Cock et al., 2009 Cock, P. J., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., ... & de Hoon, M. J. (2009). Biopython：面向计算分子生物学与生物信息学的免费Python工具. 生物信息学, 25(11), 1422–1423. https://doi.org/10.1093/bioinformatics/btp163 16. Fecher & Friesike, 2014 Fecher, B., & Friesike, S. (2014). 开放科学：一个术语，五种学派思想. EPJ数据科学（EPJ Data Science）, 3(1), 1–12. https://doi.org/10.1140/epjds/s13111-014-0006-3